Early doubts came from three places: these drugs were new and earlier weight-loss medicines had caused serious problems over time; they required either strong insurance or wealth to obtain; and users often felt ashamed, leading celebrities to claim sudden interest in walking instead of admitting the medication.
A neuroscientist noted that once GLP-1 medications reached compounding pharmacies the wellness community suddenly altered how it spoke about weight-loss treatments.